Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Controlled Trial
100%
Strength Training
100%
Breast Cancer Survivors
100%
Bone Loss
100%
Postmenopausal Breast Cancer
100%
Impact Training
100%
Risk Reduction
66%
Low Intensity
66%
Fat Mass
66%
Bone Mineral Density
66%
Lean Mass
66%
Moderate-intensity Exercise
66%
Impact Exercise
66%
Fracture Risk
66%
Intensity Resistance
66%
Aromatase Inhibitors
66%
Training Program
33%
Muscle Mass
33%
Control Program
33%
Exercise Training
33%
Non-weight Bearing
33%
Whole-body
33%
Breast Cancer Treatment
33%
Chemotherapy
33%
Obesity Risk
33%
Spine
33%
Osteoporosis
33%
Resistance Exercise
33%
Lumbar Spine
33%
Spine Bone
33%
Nave
33%
Post-irradiation
33%
Early Breast Cancer
33%
Exercise Benefits
33%
Loss Resistance
33%
Frequency Control
33%
Osteocalcin
33%
Bone Mass
33%
Targeted Exercise
33%
Serum Osteocalcin
33%
Jump Phenomenon
33%
Combined Programs
33%
Thrice Weekly
33%
Length Control
33%
Age at Diagnosis
33%
Bone-free Lean Mass
33%
Bone Turnover
33%
Stretching Program
33%
Hip Bone
33%
Obesity Phenotypes
33%
Bone Turnover Biomarkers
33%
Immunology and Microbiology
Hip
100%
Resistance Training
100%
Osteolysis
100%
Bone Turnover
100%
Bone Density
100%
Fat Mass
100%
Muscle
100%
Vertebral Column
100%
Aromatase
100%
Cross Linking
50%
Exercise
50%
Weight Bearing
50%
Lumbar Spine
50%
Bone Mass
50%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Resistance Training
100%
Bone Density
100%
Bone Turnover
100%
Aromatase Inhibitor
100%
Fat Mass
100%
Osteolysis
100%
Osteocalcin
100%
Cross-Link
50%
Exercise
50%
Weight Bearing
50%
Bone Mass
50%
Medicine and Dentistry
Resistance Training
100%
Breast Cancer
100%
Randomized Controlled Trial
100%
Osteolysis
100%
Bone Density
40%
Osteocalcin
40%
Bone Turnover
40%
Aromatase Inhibitor
40%
Cancer Therapy
20%
Exercise
20%
Cross-Link
20%
Biological Marker
20%
Dual-Energy X-Ray Absorptiometry
20%
Urinary System
20%
Weight Bearing
20%
Osteoporosis
20%
Lumbar Spine
20%
Bone Mass
20%
Diseases
20%
Chemotherapy
20%